Navigation Links
Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
Date:8/19/2007

IV-1 Test

Quantitative measurements of HIV-1 levels in blood have greatly contributed to the understanding of the process by which the virus infection leads to disease and has been shown to be an essential parameter in prognosis and management of HIV infected individuals. Decisions regarding initiation or changes in antiretroviral therapy are guided by monitoring plasma HIV-1 levels or viral load, CD4-T cell count, and the patient's clinical condition. The goal of antiretroviral therapy is to reduce the virus in plasma to below detectable levels.

The RealTime test is intended for use in conjunction with clinical presentation and other laboratory markers as an indicator of disease prognosis and for use as an aid in assessing viral response to antiretroviral treatment as measured by changes in plasma HIV-1 RNA levels. The assay is not intended to be used as a donor-screening test for HIV-1 or as a diagnostic test to confirm the presence of HIV-1 infection.

About Applera Corporation and Celera

Applera Corporation consists of two operating groups: Celera and the Applied Biosystems groups. Celera is primarily a molecular diagnostics business that is using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers, and is developing diagnostic products based on these markers as well as other known markers. Celera maintains a strategic alliance with Abbott for the development and commercialization of molecular, or nucleic acid-based, diagnostic products, and is also developing new diagnostic products outside of this alliance. Through its genomics and proteomics research efforts, Celera is also discovering and validating therapeutic targets, and has established and is seeking strategic partnerships to develop therapeutic products based on these discovered targets. The Applied Biosystems Group serves the life science industry and research community by developing and marketing instrument-based systems, con
'/>"/>

SOURCE Abbott

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6

Related medicine technology :

1. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
2. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
4. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
5. Abbotts Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
6. Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
7. Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke
8. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
9. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
10. Abbott to Present New Data Across its Vascular Portfolio at the American College of Cardiologys 56th Annual Scientific Session
11. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... N.J. , Jan. 14, 2014 InformEx, ... and sellers of high-value chemistry, will hold the 30 th ... Miami Beach Convention Center from January 21-24. ... 3,500 attendees from top pharmaceutical, fine chemical and specialty chemical ...
(Date:1/14/2014)... , Jan. 14, 2014 Animal Emergency Critical Care, a LifeCentre ... Leesburg, Virginia is the first in Loudoun ... Dr. Susan M. Barnes , Medical Director, ... and husband, Dr. Cole Taylor , are avid scuba divers. ...
(Date:1/14/2014)... WASHINGTON, New York , January 14, 2014 ... leading provider of Closed System Transfer Devices (CSTD) for hazardous drugs, today ... growth for the fourth straight year.   ... exposure for pharmacy technicians, pharmacists, nurses and other ...
Breaking Medicine Technology:Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Equashield's Sales Grow by 60% in 2013 2
... plc (Nasdaq: WCRX ) announced today that it will issue its first ... 2010 . , , , ... press release, the Company will host a conference call for all interested parties on ... review the results. To participate in the call, please dial (877) 354-4056 in ...
... PHILADELPHIA , April 29 In ... more than six million children, are known to have asthma, ... and school absenteeism. Experiencing respiratory symptoms isn,t just for people ... wheeze or feel tightness in their chest when they exercise. ...
Cached Medicine Technology:Warner Chilcott Announces Earnings Release Date and Conference Call For First Quarter 2010 Financial Results 2Teva Respiratory to Host 'Phillies Asthma Awareness Night' Featuring Free Asthma and Exercise-Induced Bronchospasm Screenings 2Teva Respiratory to Host 'Phillies Asthma Awareness Night' Featuring Free Asthma and Exercise-Induced Bronchospasm Screenings 3Teva Respiratory to Host 'Phillies Asthma Awareness Night' Featuring Free Asthma and Exercise-Induced Bronchospasm Screenings 4Teva Respiratory to Host 'Phillies Asthma Awareness Night' Featuring Free Asthma and Exercise-Induced Bronchospasm Screenings 5Teva Respiratory to Host 'Phillies Asthma Awareness Night' Featuring Free Asthma and Exercise-Induced Bronchospasm Screenings 6
(Date:4/18/2014)... How did it make you feel? According to psychologists, ... such as how sad you were or how embarrassed ... you can,t stop thinking about it. , When ... of the memories, rather than how you felt, is ... negative effects of these memories, a new study suggests. ...
(Date:4/18/2014)... Simon Fraser University psychologists have made a brain-related ... of attention-deficit disorders. , This discovery opens up ... hinder or suppress a specific brain activity that ... distraction. , The Journal of Neuroscience ... by John McDonald, an associate professor of psychology ...
(Date:4/18/2014)... in French . ... and regenerative medicine. A team led by Ludwik Leibler ... Tech) and Didier Letourneur from the Laboratoire Recherche Vasculaire ... demonstrated that the principle of adhesion by aqueous solutions ... soft-tissue organs and tissues. This easy-to-use gluing method has ...
(Date:4/17/2014)... PHILADELPHIA The presence of chronic inflammation in ... aggressive, prostate cancer, and this association was found ... levels, according to a study published in ... of the American Association for Cancer Research. , ... some participants of the placebo arm of the ...
(Date:4/17/2014)... variant specifically associated with the risk of a ... cent of all breast cancer cases. , The ... called invasive lobular carcinoma, gives researchers important clues ... of breast cancer, which can be missed through ... the journal PloS Genetics , was co-led ...
Breaking Medicine News(10 mins):Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:Scientists discover brain's anti-distraction system 2Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3
... American Cancer Society study of twelve types of cancer ... patients were significantly more likely to present with advanced ... study, which appears in the March issue of The ... to investigate insurance status and stage of diagnosis for ...
... es Salaam, Tanzania, WASHINGTON, Feb. 17 , 1:35 ... dear wife -- Mr.,President, welcome again to Amana Hospital. Well, ... for PEPFAR, the President,s,Emergency Plan for AIDS Relief., Through ... a,facility we just visited, and again, this clinic. In Dar ...
... Month, , , SUNDAY, Feb. 17 (HealthDay News) ... Americans about age-related macular degeneration (AMD), Prevent Blindness ... Month. , AMD -- a progressive disease that ... $570 million a year in direct costs for ...
... that a new wave of drug-resistant HIV is rising among among ... this trend will continue over the next few years, according to ... , At the same time, the evolution of drug-resistant HIV may ... men from becoming infected. , The model and ...
... The public health problem that needs to be addressed ... physicians who have come together to discuss the latest in ... the American Academy of Pain Medicine (AAPM), February 12-16 at ... decades, Americans, with the help of their physicians, have been ...
... people with depression , , SATURDAY, Feb. 16 (HealthDay News) -- ... syndrome (IBS) in adults, says a study by researchers at ... about 15 percent of the U.S. population. Some studies have ... some patients, but the frequency hadn,t been examined. , In ...
Cached Medicine News:Health News:Major study links insurance status to advanced stage in multiple cancers 2Health News:Remarks By President Bush and President Kikwete of Tanzania at Roundtable on Pepfar 2Health News:Don't Lose Sight of Vision Care, Group Urges 2Health News:Novel mathematical model predicts new wave of drug-resistant HIV infections in San Francisco 2Health News:Physicians focus on stopping pain epidemic 2Health News:Physicians focus on stopping pain epidemic 3Health News:Physicians focus on stopping pain epidemic 4Health News:Physicians focus on stopping pain epidemic 5Health News:Physicians focus on stopping pain epidemic 6Health News:Allergy Disorders Linked With Irritable Bowel Syndrome 2
... The patented Integra Epilepsy ... advance in the design of ... connector simplifies lead tunneling and ... cable. The Flex Connector is ...
... Foramen Ovale Electrodes provide you with an ... offer the same proven design as Ad-Techs ... are placed using an introducing needle instead ... electrode body diameter, 3 to 6 platinum ...
... Miditron Junior II is ... analyser for standardised reflectance ... and software features allow ... performance and convenience to ...
Indicated for procedures of the wrist, ankle, elbow, and other small joints, the,UltrAblator is effective for ablation of soft tissue and coagulation of bleeders,encountered during surgery....
Medicine Products: